Medifast (MED) Cash from Operations (2010 - 2026)

Medifast has reported Cash from Operations for 17 years, with the latest figure at 260000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 92.37% year-over-year to 260000.0; the trailing twelve-month figure through Mar 2026 stood at 3717000.0 (down 81.96% YoY), and the FY2025 full-year result was 6863000.0, down 71.96% from the prior year.
• Cash from Operations for Q1 2026 stood at 260000.0, up from 5278000.0 in the prior quarter.
• The five-year high for Cash from Operations was 64059000.0 in Q1 2023, with the low at 5278000.0 in Q4 2025.
• Historically, Cash from Operations has averaged 21989764.71 across 5 years, with a median of 12113000.0 in 2025.
• Annual changes were most pronounced in 2022 — Cash from Operations surged 793.65% — and 2024, when it slumped 147.02%.
• Medifast's Cash from Operations stood at 51739000.0 in 2022, then slumped by 79.66% to 10522000.0 in 2023, then slumped by 147.02% to 4947000.0 in 2024, then declined by 6.69% to 5278000.0 in 2025, then jumped by 104.93% to 260000.0 in 2026.
• The last three Cash from Operations figures came in at 260000.0 (Q1 2026), 5278000.0 (Q4 2025), and 12113000.0 (Q3 2025), per Business Quant data.